Current Pharmaceutical Design

Editorial [Hot Topic: Bilirubin Induced Neurological Damage: From the Cell to the Newborn (Executive Editor: J.D. Ostrow and C. Tiribelli)]
pp. 2868-2868(1)
Authors: Ostrow, J. D.; Tiribelli, Claudio

Bilirubin Chemistry and Metabolism; Harmful and Protective Aspects
pp. 2869-2883(15)
Authors: Vitek, Libor; Ostrow, J. D.

The Role of ABC Transporters in Protecting Cells from Bilirubin Toxicity
pp. 2884-2892(9)
Authors: Bellarosa, C.; Bortolussi, G.; Tiribelli, C.

Blood-Brain Interfaces and Bilirubin-Induced Neurological Diseases
pp. 2893-2907(15)
Authors: Ghersi-Egea, J. F.; Gazzin, S.; Strazielle, N.

Redox State, Oxidative Stress, and Molecular Mechanisms of Protective and Toxic Effects of Bilirubin on Cells
pp. 2908-2914(7)
Authors: Tell, Gianluca; Gustincich, Stefano

Contribution of Inflammatory Processes to Nerve Cell Toxicity by Bilirubin and Efficacy of Potential Therapeutic Agents
pp. 2915-2926(12)
Authors: Fernandes, Adelaide; Brites, Dora

Pharmacological Therapies for Unconjugated Hyperbilirubinemia
pp. 2927-2938(12)
Authors: Cuperus, F.J. C.; Hafkamp, A. M.; Hulzebos, C. V.; Verkade, H. J.

Intervention Guidelines for Neonatal Hyperbilirubinemia: An Evidence Based Quagmire
pp. 2939-2945(7)
Authors: Wennberg, Richard P.; Ahlfors, Charles E.; Aravkin, Aleksandr Y.

Polysulfated/Sulfonated Compounds for the Development of Drugs at the Crossroad of Viral Infection and Oncogenesis
pp. 2946-2957(12)
Authors: Rusnati, Marco; Urbinati, Chiara

Dendrimers: A Class of Polymers in the Nanotechnology for the Delivery of Active Pharmaceuticals
pp. 2958-2969(12)
Authors: Samad, Abdus; Alam, Md. I.; Saxena, Kinshuk

Hybrid Drugs for Malaria
pp. 2970-2985(16)
Authors: Walsh, J. J.; Bell, A.